Abstract

To improve the comparability of multiple sclerosis (MS) prevalence across Brazilian regions, the Brazilian Committee for Treatment and Research in MS has implemented a standardized approach to assess the prevalence of the disease in five key cities, which were deemed representative of their regions in terms of socio-geographical features and where in-person revision of each case was feasible. To report the point-prevalence of MS in Passo Fundo, one of the key cities in Southern Brazil. We sought to identify all MS patients who were living in Passo Fundo on July 1st, 2015. The primary source for case ascertainment was records from the offices of neurologists and neurosurgeons practicing in the city. Multiple secondary sources were used to maximize identification of cases. All patients underwent in-person review of the diagnosis by a panel of neurologists with experience in MS. We identified 52 MS patients living in Passo Fundo on July 1st, 2015. The point-prevalence rate for MS was 26.4/100,000 population (95% confidence interval, 19.7 to 34.6/100,000). Among the MS cases, 42 (80.8%) were female, for a sex ratio of 4.2:1. Forty-six cases (88.5%) were categorized as relapsing-remitting MS, and the remaining 6 cases, as secondary progressive MS (11.5%). Other epidemiological and clinical features were comparable to national and international MS populations. The prevalence of MS in Passo Fundo is one of the highest reported in Brazil so far. Studies in other key Brazilian cities, using the same methodology, are currently being carried out.

Highlights

  • The prevalence of multiple sclerosis (MS) reported in Brazil varies widely across regions[1], which may be due to genetic and environmental diversity as well as to methodological differences across studies

  • We aimed to report the point prevalence of MS on July 1st, 2015 in Passo Fundo, one of the key cities, which is located in Rio Grande do Sul state, Southern Brazil

  • In order to identify all patients living in Passo Fundo with an established diagnosis of MS on the prevalence day ( July 1st, 2015), we invited all adult and pediatric neurologists and neurosurgeons who were practicing in the city to provide data regarding MS cases under their care, as a primary source for case ascertainment

Read more

Summary

Introduction

The prevalence of multiple sclerosis (MS) reported in Brazil varies widely across regions[1], which may be due to genetic and environmental diversity as well as to methodological differences across studies. The Brazilian Committee for Treatment and Research in Multiple Sclerosis (BCTRIMS) has implemented a standardized approach to assess the prevalence of MS in five key cities, which were deemed representative of their regions in terms of socio-geographical features and where personal revision of each case was feasible. We aimed to report the point prevalence of MS on July 1st, 2015 in Passo Fundo, one of the key cities, which is located in Rio Grande do Sul state, Southern Brazil. To improve the comparability of multiple sclerosis (MS) prevalence across Brazilian regions, the Brazilian Committee for Treatment and Research in MS has implemented a standardized approach to assess the prevalence of the disease in five key cities, which were deemed representative of their regions in terms of socio-geographical features and where in-person revision of each case was feasible. Studies in other key Brazilian cities, using the same methodology, are currently being carried out

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call